Klinische Monatsblatter fur Augenheilkunde最新文献

筛选
英文 中文
[Visual side effects of chemotherapeutic drugs]. 【化疗药物的视觉副作用】
IF 0.8 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-23 DOI: 10.1055/a-2563-4912
Louisa M Bulirsch, Karin U Löffler, Matthias Marten Mauschitz, Martina C Herwig-Carl
{"title":"[Visual side effects of chemotherapeutic drugs].","authors":"Louisa M Bulirsch, Karin U Löffler, Matthias Marten Mauschitz, Martina C Herwig-Carl","doi":"10.1055/a-2563-4912","DOIUrl":"https://doi.org/10.1055/a-2563-4912","url":null,"abstract":"<p><p>Chemotherapeutic agents can lead to serious visual side effects in the eye, which can affect both the anterior and posterior segment. This article presents a selection of the most important chemotherapeutics causing ocular side effects. We will discuss side effects of chemotherapeutic agents that are applied directly to the eye for the treatment of an ocular neoplasia as well as side effects of systemically applied chemotherapeutic agents. Furthermore, the corresponding therapy and possible necessary adaptions of the chemotherapy are explained. Most importantly the ophthalmologist should stay in close contact with the other treating specialists.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144698931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Inherited retinal disorders: Current therapeutic options and future perspectives]. [遗传性视网膜疾病:当前的治疗选择和未来的展望]。
IF 0.8 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-23 DOI: 10.1055/a-2521-4616
Kristina Pfau, Ulrich Kellner
{"title":"[Inherited retinal disorders: Current therapeutic options and future perspectives].","authors":"Kristina Pfau, Ulrich Kellner","doi":"10.1055/a-2521-4616","DOIUrl":"https://doi.org/10.1055/a-2521-4616","url":null,"abstract":"<p><p>Inherited retinal diseases (IRDs) represent a heterogeneous group of genetically driven conditions that frequently lead to progressive vision loss. Due to their complexity and the limited therapeutic options available, they pose a significant challenge for ophthalmology. This article provides a comprehensive overview of current evidence-based therapeutic approaches, including pharmacological strategies, gene therapy, and stem cell therapy, as well as innovative developments such as optogenetics and retinal implants. While gene therapies like Luxturna for <i>RPE65</i>-associated retinitis pigmentosa have paved the way for causal treatments, initial successes are also being observed in other retinal dystrophies, such as Stargardt disease and Usher syndrome. Rehabilitative measures and interdisciplinary care remain essential to improving the quality of life for affected individuals. Future research efforts focus on enhancing the efficacy and accessibility of therapies while addressing challenges such as inflammatory reactions, high costs, and genetic variability. The perspectives outlined highlight promising advancements in the treatment of genetic retinal diseases.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144698863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Visuelle Ergebnisse einer KLEx mit einer 7,7 mm optischer Zone]. [光学带7.7 mm的KLEx的视觉结果]。
IF 0.8 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-21 DOI: 10.1055/a-2661-4897
David Dietrich Beckers, Florian Kretz, Fabian Höhn, Karen Glandorf, Detlev R H Breyer, Anke Messerschmidt-Roth, Lena Beckers
{"title":"[Visuelle Ergebnisse einer KLEx mit einer 7,7 mm optischer Zone].","authors":"David Dietrich Beckers, Florian Kretz, Fabian Höhn, Karen Glandorf, Detlev R H Breyer, Anke Messerschmidt-Roth, Lena Beckers","doi":"10.1055/a-2661-4897","DOIUrl":"https://doi.org/10.1055/a-2661-4897","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144682774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Erste Real-World-Erfahrungen mit Aflibercept 8 mg bei der Behandlung der neovaskulären AMD]. [首次在现实世界中使用Aflibercept 8mg治疗新血管性AMD]。
IF 0.8 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-15 DOI: 10.1055/a-2655-8854
Michael Grün, Kai Rothaus, Albrecht Peter Lommatzsch, Henrik Faatz
{"title":"[Erste Real-World-Erfahrungen mit Aflibercept 8 mg bei der Behandlung der neovaskulären AMD].","authors":"Michael Grün, Kai Rothaus, Albrecht Peter Lommatzsch, Henrik Faatz","doi":"10.1055/a-2655-8854","DOIUrl":"https://doi.org/10.1055/a-2655-8854","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144642895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Cystoid macular edema (CME) and immune responses after DMEK/Triple DMEK: Real-life data from Oregis]. [膀胱样黄斑水肿(CME)和DMEK/三重DMEK后的免疫反应:来自俄勒冈州的真实数据]。
IF 0.8 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-08 DOI: 10.1055/a-2650-9712
Johanna Wiedemann, Christopher Dicke, Björn O Bachmann, Lebriz Altay, Claus Cursiefen
{"title":"[Cystoid macular edema (CME) and immune responses after DMEK/Triple DMEK: Real-life data from Oregis].","authors":"Johanna Wiedemann, Christopher Dicke, Björn O Bachmann, Lebriz Altay, Claus Cursiefen","doi":"10.1055/a-2650-9712","DOIUrl":"https://doi.org/10.1055/a-2650-9712","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144591579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Patient selection for multifocal intraocular lenses]. [多焦人工晶体的患者选择]。
IF 0.7 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-01 Epub Date: 2025-05-19 DOI: 10.1055/a-2519-4324
Ramin Khoramnia, Tadas Naujokaitis
{"title":"[Patient selection for multifocal intraocular lenses].","authors":"Ramin Khoramnia, Tadas Naujokaitis","doi":"10.1055/a-2519-4324","DOIUrl":"10.1055/a-2519-4324","url":null,"abstract":"<p><p>Patient selection is the key to patient satisfaction with multifocal intraocular lenses (mIOLs). While multifocality provides spectacle independence, it is associated with potentially bothersome side effects inherent in multifocal optics. Photic phenomena such as halos and glare, as well as loss of contrast in low light environments, can be potentially problematic in visually demanding occupations and leisure activities. The use of mIOLs may also be disadvantageous in patients with certain comorbidities that affect vision or increase the risk of complications. In addition, unilateral mIOL implantation, preoperative myopia, postoperative ametropia, unrealistic patient expectations and certain personality traits may lead to lower patient satisfaction with mIOLs. Healthy, hyperopic patients with presbyopia or cataracts, a desire for spectacle independence and a willingness to compromise tend to achieve the highest satisfaction with mIOLs.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":"767-780"},"PeriodicalIF":0.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation. 在近视脉络膜新生血管患者中,球形等效物对玻璃体内抗vegf治疗的实际疗效、安全性和影响。
IF 0.7 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-01 Epub Date: 2025-06-11 DOI: 10.1055/a-2561-2847
Peter Wolfrum, Anna Maria Voigt, Katrin Lorenz, Bernhard M Stoffelns, Christina A Korb
{"title":"Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation.","authors":"Peter Wolfrum, Anna Maria Voigt, Katrin Lorenz, Bernhard M Stoffelns, Christina A Korb","doi":"10.1055/a-2561-2847","DOIUrl":"10.1055/a-2561-2847","url":null,"abstract":"<p><strong>Purpose: </strong>To analyse real-world clinical outcomes and influence of the spherical equivalent (SE) on anti-vascular endothelial growth factor (VEGF) therapy in patients affected by myopic choroidal neovascularisation (mCNV).</p><p><strong>Patients and methods: </strong>A retrospective investigation was conducted on treatment-naïve mCNV patients receiving anti-VEGF therapy at the Department of Ophthalmology, University Medical Center Mainz, Germany, between January 2018 and March 2024. Safety, functional and morphological changes in visual acuity (VA), central retinal thickness (CRT), and central retinal volume (CRV) were evaluated over a two-year period. Further, we analysed how baseline VA and CRT relate to it's final outcome measures. Finally, a subgroup analysis assessed the impact of SE above and below - 10 D.</p><p><strong>Results: </strong>Significant improvements in VA, CRT, and CRV were observed. VA improved from 0.5 ± 0.27 logMAR to 0.38 ± 0.31 logMAR (<i>p</i> = 0.005) at 6 months and remained stable at 2 years. CRT and CRV decreased from 344.4 ± 115.0 µm to 284.2 ± 45.2 µm (<i>p</i> < 0.001) and 0.27 ± 0.09 mm³ to 0.22 ± 0.04 mm³ (<i>p</i> < 0.001), respectively, four weeks after the initial injection, with stability maintained thereafter. Baseline VA correlated strongly with final VA, whereas CRT did not. No adverse events were reported. The subgroup analysis showed no significant outcome differences based on SE.</p><p><strong>Conclusion: </strong>Anti-VEGF therapy in mCNV patients proved to be safe and effective in our study with sustained improvement in functional and anatomical measures. Baseline VA strongly predicted final VA, whereas baseline and final CRT showed no association. No differences in treatment outcomes were observed as based on a varying SE.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":"745-751"},"PeriodicalIF":0.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144275276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retinal Nerve Fibre Layer OCT for Glaucoma Diagnosis - Gold Standard or Just a Piece of the Puzzle? 视网膜神经纤维层OCT诊断青光眼-金标准还是只是一块拼图?
IF 0.7 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-01 Epub Date: 2025-07-24 DOI: 10.1055/a-2501-8538
Leonie Bourauel, Karl Mercieca
{"title":"Retinal Nerve Fibre Layer OCT for Glaucoma Diagnosis - Gold Standard or Just a Piece of the Puzzle?","authors":"Leonie Bourauel, Karl Mercieca","doi":"10.1055/a-2501-8538","DOIUrl":"10.1055/a-2501-8538","url":null,"abstract":"<p><p>Early diagnosis and accurate monitoring are essential in treating glaucoma effectively and avoiding further irreversible loss of retinal ganglion cells. Glaucoma is a complex disease; initial progression is usually asymptomatic, and regular clinical and imaging examinations are extremely important. Imaging the retinal nerve fibre layer (RNFL) using spectral domain optical coherence tomography (SD-OCT) has established itself in recent years as an easy-to-perform and reproducible diagnostic method. This imaging technique allows precise analysis of the RNFL in monitoring retinal nerve fibre thickness. The present article will discuss the anatomical principles, changes to be expected in the RNFL with glaucoma compared to normal control scans, and options in analysing disease progression. We will also be discussing limitations to the method as well as additional OCT imaging techniques available. Awareness of potential sources of error makes it easier to achieve an accurate analysis of RNFL scans. Tips on interpreting RNFL scans should help ophthalmologists using the available data effectively towards reaching informed decisions on disease treatment and management in glaucoma patients.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"242 7","pages":"726-734"},"PeriodicalIF":0.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Früherkennung des Glaukoms als eine der häufigsten Erblindungsursachen – Fortschritte durch moderne Diagnostik mit OCT. 青光眼作为最常见的失明原因之一的早期发现-现代近距离CT诊断的进展。
IF 0.7 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-01 Epub Date: 2025-07-24 DOI: 10.1055/a-2579-7419
Verena Prokosch, Carl Erb
{"title":"Früherkennung des Glaukoms als eine der häufigsten Erblindungsursachen – Fortschritte durch moderne Diagnostik mit OCT.","authors":"Verena Prokosch, Carl Erb","doi":"10.1055/a-2579-7419","DOIUrl":"https://doi.org/10.1055/a-2579-7419","url":null,"abstract":"","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":"242 7","pages":"711"},"PeriodicalIF":0.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient Reported Outcomes of Retrobulbar versus Topical Anaesthesia in Cataract Surgery - a Prospective Observational Trial. [患者报告的后球囊与局部麻醉的结果]。
IF 0.7 4区 医学
Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-01 Epub Date: 2025-05-19 DOI: 10.1055/a-2616-2773
Vera Kanlic, Andreas Guttmann, Andreas Wedrich, Domagoj Ivastinovic
{"title":"Patient Reported Outcomes of Retrobulbar versus Topical Anaesthesia in Cataract Surgery - a Prospective Observational Trial.","authors":"Vera Kanlic, Andreas Guttmann, Andreas Wedrich, Domagoj Ivastinovic","doi":"10.1055/a-2616-2773","DOIUrl":"10.1055/a-2616-2773","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this prospective clinical, monocentric observational study was to assess the pain perception of patients during cataract surgery.</p><p><strong>Methodology: </strong>Patients undergoing cataract surgery at the Department of Ophthalmology at the Medical University of Graz were recruited. Patients who received retrobulbar anaesthesia (RBA) were compared to those who received topical drop anaesthesia (TA) with (TAG) or without an anaesthetic gel. Exclusion criteria were complications during the cataract surgery requiring additional steps including anterior vitrectomy and the placement of a Malyugin ring. The patients were interviewed postoperatively regarding their perceived pain experience during cataract surgery, using the Numeric Rating Scale. Additionally, the mean intraoperative blood pressure was recorded for correlation with the subjective assessment of pain.</p><p><strong>Results: </strong>Overall, 201 patients could be enrolled. Among them, 105 patients underwent cataract surgery under RBA, 50 patients under TA and 46 patients under TAG. The average pain score under RBA was 0.35 ± 0.87, under TA 1.32 ± 1.22, and under TAG 0.89 ± 0.97. Statistical analysis revealed a significant difference between RBA and the two topical anaesthesia methods (p < 0.01). However, no significant difference was found between the two topically applied methods, TA and TAG (p = 0.64). The mean intraoperative blood pressure could be obtained for a total of 32 patients. The average difference in values before and during the operation was + 1.88 mmHg under RBA and + 3.33 mmHg under TAG (p > 0.05).</p><p><strong>Conclusion: </strong>Our results indicate that patients receiving RBA have significantly less pain intraoperatively than those with TA and TAG. The addition of an anaesthetic gel to TA showed a slight, but not significant, reduction in pain.</p>","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":"741-744"},"PeriodicalIF":0.7,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144102175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信